[ad_1]
As China prepared for the risk of increasing the transmission rate of the epidemic during the winter, by giving the first approval to the vaccine from the state pharmaceutical company Sinopharm, it took a step towards the widespread use of the first coronavirus vaccine. in the country.
Although there are no detailed data on the vaccine’s effectiveness, the Beijing Biological Products Institute unit of the China National Biotec Group (CNBG), a subsidiary of Sinopharm, which developed the vaccine, announced that the vaccine had a 79.34 percent percent effectiveness against the disease, according to provisional data.
FREE APPLICABLE
Some of the vaccines, which are undergoing third-stage clinical trials in China, have previously received approval for emergency use. In this context, it has been reported that 4.5 million doses of vaccine have been used since the beginning of June and high-risk groups have been vaccinated, including health workers, customs personnel and government officials traveling to the Exterior.
On the other hand, Zeng Yixin, vice chairman of the National Health Commission of China, said that Covid-19 vaccines will be offered to the public for free.
CUREVAC IS EXPECTING THREE COUNTRIES
While there have been approved human trials for 14 vaccine candidates in China so far, 5 of them have been reported to have moved on to stage three of clinical trials.
The vaccine, which was purchased for curevac Turkey, Brazil, following the results of studies in Indonesia and Turkey, is expected to be approved by China.
It may interest you
It may interest you
[ad_2]
